Ames, Iowa (March 23, 2016) – In January,
GlobalVetLINK (GVL®) added Kavault® to its FeedLINK®
electronic Veterinary Feed Directive (eVFD) system. Kavault
is a new swine antibiotic from Elanco Animal Health for
reduction in incidence and overall severity of diarrhea in
the presence of pathogenic Escherichia coli in groups of
weaned pigs that is only available with a VFD.
Elanco has partnered with GVL since the FeedLINK system was
launched in 2005. The addition of Kavault to FeedLINK
provides veterinarians, producers and feed distributors with
a complete solution for compliance with FDA guidance.
“Kavault is a first-in-class, animal use-only antibiotic to
be used under the supervision of a veterinarian when nursery
pigs are most vulnerable and E. coli can cause significant
performance loss and even death,” said Dr. Thomas Marsteller,
director of swine technical consulting for Elanco. “Having
an electronic VFD option for Kavault makes compliance with
this important new treatment option much easier for the
FeedLINK powered by GVL SmartEngine™ technology is a
web-based system that streamlines fulfillment, tracking and
storage of VFDs. Once a VFD is completed, the veterinarian
can sign it and immediately email a copy to the producer for
record keeping and the feed manufacturer for fulfillment.
Feed distributors can now have their own account to access
and store the VFDs they have received.
“Practitioners have used FeedLINK for over ten years to
prescribe VFD drugs for swine and cattle,” said Cliff Smith,
GVL Chief Executive Officer. “Vets are preparing for
additional VFD drugs in 2017, and FeedLINK is recognized by
the industry as the only fully operational, complete
electronic VFD solution.”
Patent-pending GVL SmartEngine technology, which powers the
FeedLINK system, ensures that the vet inputs the correct
information – species, production class, drug specifications
– when creating a VFD and verifies the entire certificate
for accuracy, completeness and compliance.
To learn more about the FeedLINK eVFD System, visit